Albumin depletion of human plasma also removes low abundance proteins including the cytokines

The use of proteomics for efficient, accurate, and complete analysis of clinical samples poses a variety of technical challenges. The presence of higher abundance proteins in the plasma, such as albumin, may mask the detection of lower abundance proteins such as the cytokines. Methods have been proposed to deplete the sample of these higher abundance proteins to facilitate detection of those with lower abundance. In this study, a commercially available albumin depletion kit was used to determine if removal of albumin would measurably reduce detection of lower abundance cytokine proteins in human plasma. The Montage® Albumin Deplete Kit (Millipore) was used to deplete albumin from LPS‐stimulated whole blood from 15 normal human donors. Albumin depletion was measured using the BCG reagent and SDS‐PAGE, and cytokine recovery was determined by a microassay immunoassay that measures both pro‐ and anti‐inflammatory cytokines. Average albumin depletion from the samples was 72%. However, several cytokines were also significantly reduced when the albumin was removed from the plasma. Additionally, there was a variable reduction in cytokine recovery from a known mixture of cytokines in a minimal amount of plasma that were loaded onto the columns. These data demonstrate that there may be a non‐specific loss of cytokines following albumin depletion, which may confound subsequent proteomic analysis.

[1]  D. Johnson,et al.  Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. , 1976, The Biochemical journal.

[2]  P. Arnaud,et al.  Chromatography of plasma proteins on immobilized Cibacron Blue F3-GA. Mechanism of the molecular interaction. , 1982, The Biochemical journal.

[3]  P. Arnaud,et al.  A general method for fractionation of plasma proteins. Dye-ligand affinity chromatography on immobilized Cibacron blue F3-GA. , 1982, The Biochemical journal.

[4]  K. Rengarajan,et al.  Removal of albumin from multiple human serum samples. , 1996, BioTechniques.

[5]  B. Lollo,et al.  Improved two‐dimensional gel electrophoresis representation of serum proteins by using ProtoClearTM , 1999, Electrophoresis.

[6]  P. Righetti,et al.  A turning point in proteome analysis: Sample prefractionation via multicompartment electrolyzers with isoelectric membranes , 2000, Electrophoresis.

[7]  K. Bommert,et al.  Prefractionation of protein samples for proteome analysis using reversed‐phase high‐performance liquid chromatography , 2001, Electrophoresis.

[8]  R. Ozols,et al.  The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics. , 2002, Cancer cell.

[9]  E. H. Cohen,et al.  Development of Mammalian Serum Albumin Affinity Purification Media by Peptide Phage Display , 2002, Biotechnology progress.

[10]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[11]  J. Siddiqui,et al.  Six at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days , 2002, Shock.

[12]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[13]  G. Rice,et al.  An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum , 2003, Proteomics.

[14]  T. M. Thomas,et al.  Depletion of the highly abundant protein albumin from human plasma using the Gradiflow , 2003, Proteomics.

[15]  Andrea Tannapfel,et al.  Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays , 2003, The Journal of pathology.

[16]  Emanuel F. Petricoin,et al.  Biomarker Amplification by Serum Carrier Protein Binding , 2004, Disease markers.

[17]  P. Haney,et al.  SwellGel: a sample preparation affinity chromatography technology for high throughput proteomic applications. , 2003, Protein expression and purification.

[18]  S. Kingsmore,et al.  Cerebral palsy is characterized by protein mediators in cord serum , 2004, Annals of neurology.

[19]  L. Melton Protein arrays: Proteomics in multiplex , 2004, Nature.

[20]  A. Chinnaiyan,et al.  Development of a Sensitive Microarray Immunoassay and Comparison With Standard Enzyme-Linked Immunoassay for Cytokine Analysis , 2004, Shock.

[21]  R. Jonsson,et al.  Circulating Cytokines in Primary Sjögren's Syndrome Determined by a Multiplex Cytokine Array System , 2004, Scandinavian journal of immunology.

[22]  Montserrat Carrascal,et al.  Determination of protein markers in human serum: Analysis of protein expression in toxic oil syndrome studies , 2004, Proteomics.